Poland · Delayed Price · Currency is PLN Diagnostyka Statistics
Total Valuation
Diagnostyka has a market cap or net worth of PLN 5.93 billion. The enterprise value is 7.02 billion.
| Market Cap | 5.93B |
| Enterprise Value | 7.02B |
Important Dates
The last earnings date was Thursday, May 28, 2026.
| Earnings Date | May 28, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
Diagnostyka has 33.76 million shares outstanding.
| Current Share Class | 33.76M |
| Shares Outstanding | 33.76M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 51.42% |
| Owned by Institutions (%) | 27.14% |
| Float | 16.40M |
Valuation Ratios
The trailing PE ratio is 22.70 and the forward PE ratio is 20.12. Diagnostyka's PEG ratio is 0.59.
| PE Ratio | 22.70 |
| Forward PE | 20.12 |
| PS Ratio | 2.36 |
| PB Ratio | 9.48 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.59 |
| P/OCF Ratio | 10.64 |
| PEG Ratio | 0.59 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.61, with an EV/FCF ratio of 19.65.
| EV / Earnings | 26.87 |
| EV / Sales | 2.80 |
| EV / EBITDA | 11.61 |
| EV / EBIT | 17.84 |
| EV / FCF | 19.65 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.77.
| Current Ratio | 0.80 |
| Quick Ratio | 0.68 |
| Debt / Equity | 1.77 |
| Debt / EBITDA | 1.83 |
| Debt / FCF | 3.09 |
| Interest Coverage | 5.67 |
Financial Efficiency
Return on equity (ROE) is 48.05% and return on invested capital (ROIC) is 19.81%.
| Return on Equity (ROE) | 48.05% |
| Return on Assets (ROA) | 12.27% |
| Return on Invested Capital (ROIC) | 19.81% |
| Return on Capital Employed (ROCE) | 23.99% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 290,450 |
| Profits Per Employee | 30,225 |
| Employee Count | 8,645 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 9.61 |
Taxes
In the past 12 months, Diagnostyka has paid 55.14 million in taxes.
| Income Tax | 55.14M |
| Effective Tax Rate | 16.82% |
Stock Price Statistics
The stock price has increased by +7.19% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +7.19% |
| 50-Day Moving Average | 164.86 |
| 200-Day Moving Average | 179.84 |
| Relative Strength Index (RSI) | 58.07 |
| Average Volume (20 Days) | 42,067 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Diagnostyka had revenue of PLN 2.51 billion and earned 261.30 million in profits. Earnings per share was 7.74.
| Revenue | 2.51B |
| Gross Profit | 1.99B |
| Operating Income | 393.54M |
| Pretax Income | 327.83M |
| Net Income | 261.30M |
| EBITDA | 604.81M |
| EBIT | 393.54M |
| Earnings Per Share (EPS) | 7.74 |
Balance Sheet
The company has 36.49 million in cash and 1.11 billion in debt, with a net cash position of -1.07 billion or -31.68 per share.
| Cash & Cash Equivalents | 36.49M |
| Total Debt | 1.11B |
| Net Cash | -1.07B |
| Net Cash Per Share | -31.68 |
| Equity (Book Value) | 625.82M |
| Book Value Per Share | 17.91 |
| Working Capital | -113.54M |
Cash Flow
In the last 12 months, operating cash flow was 557.45 million and capital expenditures -200.03 million, giving a free cash flow of 357.42 million.
| Operating Cash Flow | 557.45M |
| Capital Expenditures | -200.03M |
| Depreciation & Amortization | 211.28M |
| Net Borrowing | -49.89M |
| Free Cash Flow | 357.42M |
| FCF Per Share | 10.59 |
Margins
Gross margin is 79.26%, with operating and profit margins of 15.67% and 10.41%.
| Gross Margin | 79.26% |
| Operating Margin | 15.67% |
| Pretax Margin | 13.06% |
| Profit Margin | 10.41% |
| EBITDA Margin | 24.09% |
| EBIT Margin | 15.67% |
| FCF Margin | 14.23% |
Dividends & Yields
This stock pays an annual dividend of 4.40, which amounts to a dividend yield of 2.48%.
| Dividend Per Share | 4.40 |
| Dividend Yield | 2.48% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 42.76% |
| Buyback Yield | n/a |
| Shareholder Yield | 2.48% |
| Earnings Yield | 4.41% |
| FCF Yield | 6.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Diagnostyka is 206.28, which is 17.87% higher than the current price. The consensus rating is "Buy".
| Price Target | 206.28 |
| Price Target Difference | 17.87% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 12.37% |
| EPS Growth Forecast (3Y) | 16.73% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Diagnostyka has an Altman Z-Score of 4.2 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.2 |
| Piotroski F-Score | 4 |